GL1X · GenesisL1 explorer

MolNFT v1 · #90012 · protein

JAK2 kinase (JH1 domain) triple mutant in complex with compound 7

4E6D · Tyrosine-protein kinase JAK2: “JAK2 kinase (JH1 domain) triple mutant in complex with compound 7”. X-ray diffraction, 1 ligand (0NU), 3 pockets (best druggability 0.80). MolNFT v1 #90012 on GenesisL1: 3D structure, binding sites and…

PDB
4E6D
Type
protein
Length
576 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
0NU
Pockets
3 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28844% helix, 18% strandO60674

Ligands and binding sites

  • 0NU · 3-[(3R)-3-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)piperidin-1-yl]-3-oxopropanenitrile · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110730.800.821030NU, GOL
21970.620.83250NU
31580.600.8429empty

Interfaces

1 interface between chains.

  • A–B · 511 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 4E6D · JAK2 kinase (JH1 domain) triple mutant in complex with compound 7 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.